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ANNOUNCEMENT 
The Ninth Combined Skin Pathology Course and The Fifth Annual Workshop in Dermato-
pathology sponsored by Scripps Clinic and Research Foundation, will be held at the Sheraton 
Grande Torrey Pines Hotel, La Jolla, California, September 17 - 21, 1994. 
The program will be based on a rigorous, comprehensive, and practical review of dermato-
pathology. Microscopic sessions will be conducted, and the workshop approach will include 
demonstration and unknown slides. The course will offer 40 hours of Category I CME credit. 
The Course Director will be James H. Graham, M.D., Head, Division of Dermatopathology. 
For further information contact: Department of Academic Affairs, 403C, Scripps Clinic and 
Research Foundation, 10666 N. Torrey Pines Road, La JoUa, CA 92037. Telephone, (619) 
554-8556; FAX, (619) 554-6310. 
